Tag: Neulasta
US FDA approves Mylan & Biocon’s biosimilar, Fulphila
Second FDA-approved biosimilar through the Mylan-Biocon collaboration,, Fulphila is expected to be the first biosimilar pegfilgrastim available in the U.S. to help patients with nonmyeloid cancers reduce the risk of infection...............